hepatitis C

June 14 P&P Quick Takes: Washington state approved for subscription HCV model; plus Merck and IBM, BGI, and more
BioCentury
Sat, 06/15/19 - 05:54 pm
Washington
Netflix model
hepatitis C
BGI Genomics
China
distribution
AbbVie wins hep C contract with Washington state in latest 'Netflix' deal
Biopharma Dive
Fri, 04/26/19 - 07:45 pm
AbbVie
hepatitis C
Netflix model
Washington state
Louisiana has picked its 'Netflix' hepatitis C partner: Gilead's new generics unit
Fierce Pharma
Wed, 03/27/19 - 11:45 am
Louisiana
Gilead Sciences
hepatitis C
Asegua Therapeutics
Netflix model
Louisiana's 'Netflix' deal for hepatitis C drugs wins bids from AbbVie, Gilead and Merck
Fierce Pharma
Thu, 03/7/19 - 09:19 pm
hepatitis C
AbbVie
Gilead Sciences
Louisiana
Netflix model
Study shows Purdue’s switch to ‘abuse-deterrent’ OxyContin helped drive a spike in hepatitis C infections
Stat
Tue, 02/5/19 - 11:27 pm
Purdue Pharma
oxycontin
abuse-resistant painkillers
hepatitis C
Gilead's hepatitis C generics are on their way, but Epclusa's getting TV ads anyway
Fierce Pharma
Mon, 02/4/19 - 11:40 am
Gilead Sciences
hepatitis C
Epclusa
drug ads
television ads
7 Things to Expect for Gilead Sciences in 2019
Motley Fool
Tue, 01/8/19 - 09:12 am
Gilead Sciences
JPMHC 2019
HIV
hepatitis C
M&A
Daniel O'Day
Did Gilead Sciences Make an $11 Billion Blunder?
Motley Fool
Sun, 12/9/18 - 03:53 pm
Gilead Sciences
Pharmasset
hepatitis C
AbbVie inks licensing deal to boost Mavyret access in nearly 100 countries
Fierce Pharma
Tue, 11/13/18 - 10:24 pm
AbbVie
hepatitis C
Mavyret
Medicines Patent Pool
Merck asks SCOTUS for its $200M in Gilead patent dues, never mind the misconduct
Fierce Pharma
Wed, 09/26/18 - 07:21 pm
Merck
Supreme Court
Gilead Sciences
hepatitis C
Express Scripts praises, then takes credit for Gilead's authorized generics launches
Fierce Pharma
Tue, 09/25/18 - 11:47 am
Gilead Sciences
Express Scripts
generics
hepatitis C
Gilead to Launch Authorized Generic Versions of Epclusa and Harvoni for Chronic Hepatitis C
CP Wire
Mon, 09/24/18 - 09:34 am
Gilead Sciences
generics
Epclusa
Harvoni
hepatitis C
Asegua Therapeutics
Inovio launches Ph1 study of Hep C vaccine
Drug Delivery Business News
Tue, 09/4/18 - 09:47 am
Inovio
vaccines
GeneOne Life Science
hepatitis C
GLS-6150
Louisiana seeking comments on 'Netflix' model for hepatitis C drugs
Fierce Pharma
Thu, 08/16/18 - 11:25 pm
hepatitis C
Medicaid
Louisiana
2019 Express Scripts Formulary Exclusions: Hepatitis C Changes Show Why the Drug Channel Must Change, Too
Drug Channels
Thu, 08/16/18 - 12:24 pm
Express Scripts
CVS Health
formulary
drug channels
hepatitis C
Gilead loses key patent claims for Sovaldi in China, opening door to earlier generic entry
Endpoints
Tue, 08/14/18 - 06:38 pm
China
Gilead Sciences
hepatitis C
generics
Sovaldi
Merck’s 60% price cut for hepatitis C drug nets company a big sales opportunity
Marketwatch
Wed, 08/8/18 - 12:00 am
Merck
Express Scripts
hepatitis C
Zepatier
Express Scripts to Drop Big Sellers From AbbVie, Gilead in 2019
Bloomberg
Tue, 08/7/18 - 11:24 am
Express Scripts
PBMs
Gilead Sciences
HIV
Atripla
AbbVie
Mavyret
hepatitis C
AbbVie surprised investors with its hepatitis C success. Will it last?
Biopharma Dive
Sat, 08/4/18 - 11:43 am
AbbVie
hepatitis C
Mavyret
Merck touts a 60% price cut, but the drug is outdated and on the way out
Marketwatch
Sat, 07/21/18 - 02:09 pm
Merck
Zepatier
hepatitis C
drug pricing

Pages